- Home
- NXDT vs FENC Comparison
NXDT vs FENC Comparison
Compare NXDT & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXDT
- FENC
- Stock Information
- Founded
- NXDT 2012
- FENC 1996
- Country
- NXDT United States
- FENC United States
- Employees
- NXDT N/A
- FENC N/A
- Industry
- NXDT Investment Managers
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXDT Finance
- FENC Health Care
- Exchange
- NXDT Nasdaq
- FENC Nasdaq
- Market Cap
- NXDT 156.8M
- FENC 156.9M
- IPO Year
- NXDT N/A
- FENC 2001
- Fundamental
- Price
- NXDT $3.75
- FENC $5.08
- Analyst Decision
- NXDT
- FENC Strong Buy
- Analyst Count
- NXDT 0
- FENC 2
- Target Price
- NXDT N/A
- FENC $14.00
- AVG Volume (30 Days)
- NXDT 133.6K
- FENC 87.7K
- Earning Date
- NXDT 01-01-0001
- FENC 05-13-2025
- Dividend Yield
- NXDT 9.66%
- FENC N/A
- EPS Growth
- NXDT N/A
- FENC N/A
- EPS
- NXDT 0.99
- FENC N/A
- Revenue
- NXDT N/A
- FENC $47,538,000.00
- Revenue This Year
- NXDT N/A
- FENC $2.68
- Revenue Next Year
- NXDT N/A
- FENC $71.63
- P/E Ratio
- NXDT $6.41
- FENC N/A
- Revenue Growth
- NXDT N/A
- FENC 123.69
- 52 Week Low
- NXDT $5.89
- FENC $3.96
- 52 Week High
- NXDT $13.07
- FENC $10.07
- Technical
- Relative Strength Index (RSI)
- NXDT 44.42
- FENC 34.36
- Support Level
- NXDT $3.41
- FENC $5.02
- Resistance Level
- NXDT $4.32
- FENC $5.50
- Average True Range (ATR)
- NXDT 0.29
- FENC 0.41
- MACD
- NXDT 0.03
- FENC -0.03
- Stochastic Oscillator
- NXDT 52.50
- FENC 22.22
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.